Since 2021, McGuireWoods’ Ponzi Litigation team has been tracking and posting case alerts on Ponzi-related complaints filed in federal and state courts throughout the country and analyzed key decisions that have the potential to influence controlling law on Ponzi-related issues. The blog also posts practical considerations like effective defenses to dismiss Ponzi litigation and common
Healthcare & Life Sciences Private Equity Deal Tracker: TT Capital Partners Acquires Pyx Health
TT Capital Partners (TTCP) has made a majority growth investment in Pyx Health, according to a news release.
Pyx Health, based in Tucson, Ariz., is the developer of a solution designed to address loneliness and social isolation. Founded in 2017, the company works with major payers as well as government, employer and community…
Women in PE to Know: Ewelina Woloszyn
McGuireWoods has long been an avid supporter of the advancement of professional women. As part of our initiative seeking to expand the leadership of women in private equity, we are continuing our series of profiling women leaders in private equity. We are hopeful that this series will serve to inspire other women to pursue their…
FTC Continues Tough “Made in USA” Enforcement Even Where Labeling Rule Is Not Violated
By Wrede Smith
On June 26, the Federal Trade Commission announced a proposed consent order resolving allegations against a group of leather and other clothing accessory companies regarding Made in USA claims in online and print materials and qualified Made in USA claims on product labels. Read on for details about this enforcement action and key takeaways for…
DHS Issues Final Rule Regulating Federal Contractors’ Handling of Controlled Unclassified Information
On June 21, the U.S. Department of Homeland Security issued a long-anticipated cybersecurity final rule that revises an existing clause and adds two new clauses to the Homeland Security Acquisition Regulation related to contractors’ handling of controlled unclassified information.
Read on for highlights from this rule, which goes into effect July 21 and is likely to…
Healthcare & Life Sciences Private Equity Deal Tracker: Thoma Bravo Invests in Bluesight
Thoma Bravo has announced it has completed a growth investment in Bluesight.
Bluesight, based in Alexandria, Va., is a developer of software supporting the pharmacy supply chain. Founded in 2011, the company’s solutions include those for inventory management, controlled substance diversion prevention and medication purchasing.
Thoma Bravo, with offices in Chicago and San…
Regional Hospital System and Two Physicians Pay More Than $69 Million to Settle False Claims Act, Involving Allegations of Improper Financial Relationships With Referring Physicians
On March 29, 2023, the U.S. District Court for the Eastern District of Michigan granted the parties’ joint stipulation for dismissal in U.S. ex. rel. Godsholl v. Covenant Healthcare, following three settlements of the relator’s claims pursuant to the False Claims Act, 31 U.S.C. § 3729 (“FCA”), the Michigan Medicaid False Claim Act, MCL 400.601, et seq., the Federal Anti-Kickback Statute, 42 U.S.C. 1320a-7b(b) (“AKS”), and the Stark Act, 42 U.S.C. § 1395nn (“Stark”), alleging that a regional hospital system engaged in improper financial relationships with referring physicians. The settlement payments total more than $69 million.
WCAS Closes New Fund With More Than $5 Billion
Welsh, Carson, Anderson & Stowe (WCAS) has announced it has closed its latest fund with more than $5 billion in commitments.
The new fund, WCAS XIV, exceeded its target and the firm’s prior fund, which closed at $4 billion.
WCAS, based in New York, is a private equity firm focused exclusively on the healthcare…
WindRose Closes New Fund With More Than $1.4 Billion
WindRose Health Investors has announced it has closed its latest fund with more than $1.4 billion in commitments.
The new fund, WindRose Health Investors VI, exceeded the size of its $705 million predecessor fund.
WindRose, based in New York, pursues control equity investments in healthcare companies. Founded in 2000, the firm invests in a broad range…
Complex AKS/Stark Complaint Survives Rule 9(b) Particularity Challenge – A Guide for FCA Complaints
In U.S. v. Genesis Global Healthcare, 2023 WL 3656925 (S.D. Ga. May 25, 2023), a Georgia district court denied three (3) Motions to Dismiss the Second Amended Complaint filed in a qui tam action brought by relators under the False Claims Act (the “FCA”) and the Georgia False Medicaid Claims Act. The court, having previously held that the relators’ First Amended Complaint amounted to an improper shotgun pleading, found that the Second Amended Complaint adequately remedied the court’s concerns. The court’s ruling reaffirms the pleading standards of claims brought under the FCA and serves as a guide for both courts and parties alike to the pleading requirements a complaint must satisfy to survive a motion to dismiss.